MRNA
Moderna, Inc.
NASDAQ · Healthcare · Biotechnology · US
$154.04
−2.55%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 31.58x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 9.10x
- Price / sales
- 27.60x
- Price / cash flow
- -58.46x
Enterprise value
- Enterprise value
- $57.6B
- EV / sales
- 25.87x
- EV / EBITDA
- -20.38x
- EV / EBIT
- -17.36x
- Market cap
- $61.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026